2care4 Generics ApS: Financial statements 2023
CVR: 36960566
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
2care4 Generics ApS (CVR 36960566) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 73,414,000 and a net result of DKK 31,564,000 compared with DKK 34,598,000 the year before. That is a decrease of 3% compared with the year before. Equity in the 2023 report amounted to DKK 86,544,000. The solvency ratio was 50.8%. The company had 15 employees in the financial year.
- Gross Profit
- DKK 73,414,000
- Profit/Loss
- DKK 31,564,000
- Equity
- DKK 86,544,000
- Total Assets
- DKK 170,370,000
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 73.4 mio. | 31.6 mio. | 86.5 mio. | 15 |
| 2022 | - | 75.7 mio. | 34.6 mio. | 74.2 mio. | 12 |
| 2021 | - | 55.9 mio. | 29.1 mio. | 44.6 mio. | 15 |
| 2020 | - | 32.9 mio. | 15.7 mio. | 15.5 mio. | 12 |
| 2019 | - | 8 mio. | -599 t. | -166 t. | 8 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
2care4 Generics ApS has published its annual report for 2022. Gross profit came to DKK 75,691,000, and the net result was DKK 34,598,000.
About 2care4 Generics ApS
2care4 Generics ApS is a Danish company of the type Anpartsselskab based in Esbjerg V, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Erik Sandberg. The board consists of Toke Værndal. The company is owned by 2care4 Group ApS. The company has 7 employees (2018). In 2025, the company reported a gross profit of DKK 52,415,000 and a net result of DKK 11,207,000 compared with DKK 17,193,000 the year before. Equity in the 2025 report amounted to DKK 49,944,000.